Multigene Expression Biomarkers and Score Systems for Predicting Therapeutic Benefit in Gastrointestinal Cancers

Abstract

Gastrointestinal cancer is a leading cause of death among cancer patients worldwide. For both gastric and colorectal cancers, the 5-year overall survival for advanced stages remains low. Their polygenic and heterogeneous nature is characterized by alterations in multiple Note to the Reader: This chapter is part of the book Gastrointestinal Cancers